Our findings demonstrate that the NLR, CRP/Alb ratio and PLR were all associated with a poor prognosis in Xp11.2 tRCC patients. This evidence concerns the gene CRP and renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions.